Chemical Compound

(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene-4-carboxamide

Name: (2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene-4-carboxamide
Brand: EASY CDMO
SKU: 10531

CAS Registry Number 511-12-6

返回搜索申请报价

$(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene-4-carboxamide 结构式$

Primary record

(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene-4-carboxamide

库存: 2,613 克
纯度: 98.3 %
CAS: 511-12-6

化合物标识与属性

CAS: 511-12-6
PubChem CID: 10531
SMILES: C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C
Canonical SMILES: CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21

名称与同义词

dihydroergotamine
Dihidroergotamina
Neomigran
Levadex
9,10-Dihydroergotamine
Diidroergotamina
Agit
Dihydroergotaminum
Dehydroergotamine
Dihydergot
Ergomimet
Orstanorm
Migranal
Dergotamine
Endophleban
Angionorm
Dirgotarl
Ergotonin
Tonopres
Verladyn
Diergo
Ergont
Ikaran
Morena
Seglor
Dihydroergotoxin
Co-Dergocrine
Tempo Migraine
DHE ratiopharm
Neomigran (TN)
Dihydroergotamine mesylate
Diidroergotamina [DCIT]
Von Ct, Ergotam
DHE Puren
Migranal (TN)
Dihydroergotaminum [INN-Latin]
DIHYDROERGOTOXINE
9,10-dihydro-ergotamine
DET MS
Dihidroergotamina [INN-Spanish]
ERGOTAMINE
Ergotoxine, dihydro-
Dihydroergotamine (INN)
Dihydroergotamine [INN]
Dihydroergotamine nasal
Ergoloid dihydroergotoxine
Dihydroergotamine Sandoz
Dihydroergotamine-Sandoz
Spectrum_001057
MAP0004
Ergotamine, 9,10-dihydro-
Inhaled DHE, Sheffield
RefChem:55021
Dihydroergotamine methanesulfonate
AC1L1VEA
Dihydroergotamine mesilate
Dihydroergotamine tartrate
511-12-6
Spectrum2_001188
Spectrum3_000395
Spectrum4_000958
Spectrum5_000905
CHEMBL1732
DHE-45
D Tamin retard L.U.T.
Dihydroergotamine [INN:BAN]
DTXSID6045614
Ergot Alkaloids, Hydrogenated
D0O4CV
D0V3ZA
MAP-0004
UNII-436O5HM03C
CHEBI:4562
Dihydroergotamine (mesylate)
436O5HM03C
Lopac0_000357
SCHEMBL44931
BSPBio_002209
DTXCID4025614
GTPL121
KBioGR_001576
KBioSS_001537
BIDD:GT0120
DIHYDROERGOTAMINE [MI]
DivK1c_000592
EINECS 208-123-3
SPBio_001235
LUZRJRNZXALNLM-JGRZULCMSA-N
C33H37N5O5
D.H.E.
MAP 0004
SCHEMBL29542581
DIHYDROERGOTAMINE [VANDF]
KBio1_000592
KBio2_001537
KBio2_004105
KBio2_006673
KBio3_001429
BRN 5720196
DIHYDROERGOTAMINE [MART.]
Dihydroergotamine monomethanesulfonate
N02CA01
Nasal DHE (migraine), Britannia
D.H.E. 45
NINDS_000592
Tempo dyhydroergotamine, Sheffield
DIHYDROERGOTAMINE [WHO-DD]
CID10531
ZINC3978005
Tox21_110821
BDBM50295557
EBC-27353
ErgoloidMesylates (dihydroergotoxine)
NCGC00017400-05
C33-H37-N5-O5
Ergoloid Mesylates (dihydroergotoxine)
Tox21_110821_1
CCG-204452
DB00320
J6.263D
SDCCGSBI-0050345.P005
IDI1_000592
Dihydroergotamine (inhaled, Tempo), MAP
NCGC00017400-06
NCGC00017400-07
NCGC00017400-08
NCGC00017400-10
AN-45444
CAS-511-12-6
LS-61979
LS-64563
Dihydroergocristine Mesilate EP Impurity E
SBI-0050345.P004
4689B
C07798
D07837
Dihydroergotamine (nasal, migraine), Britannia
42124-EP2275420A1
42124-EP2280008A2
42124-EP2298764A1
42124-EP2298765A1
42124-EP2311808A1
42124-EP2311829A1
AB00053458_03
5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
511D126
Brekiya (dihydroergotamine mesylate auto-injector)
Dihydroergotamine (inhaled/oral, Tempo), Sheffield
EN300-26508628
Q421336
9,10-Dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
BRD-K72166146-066-02-1
BRD-K72166146-066-03-9
BRD-K72166146-066-04-7
BRD-K72166146-066-05-4
CODERGOCRINE MESILATE IMPURITY D [EP IMPURITY]
Dihydroergotamine (migraine,Tempo-inhaled/oral), MAP
DHE
(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
6190-39-2
Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha,10alpha)-
(10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carboxamide
(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide
(5'alpha)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman
(6aR,9R,10aR)-N-((2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
(10alpha)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
(5'alpha)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
5'alpha-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-10alpha-9,10-dihydroergotaman
(2R,4R,7R)-N-((1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo(7.3.0.0^(2,6))dodecan-4-yl)-6-methyl-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),9,12,14-tetraene-4-carboxamide
(2R,4R,7R)-N-((1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo(7.3.0.02,6)dodecan-4-yl)-6-methyl-6,11-diazatetracyclo(7.6.1.02,7.012,16)hexadeca-1(16),9,12,14-tetraene-4-carboxamide
(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene-4-carboxamide
(5'-alpha,10-alpha)-9,10-Dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotaman-3',6',18-trione
(5'alpha,10alpha)-9,10-Dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotaman-3',6',18-trione
(5alpha,5'beta,10alpha)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
(6aR,9R,10aR)-N-((1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo(7.3.0.02,6)dodecan-4-yl)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo(4,3-fg)quinoline-9-carboxamide
(6aR,9R,10aR)-N-((2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
208-123-3
2GM
7-Methyl-4,6,6a,7,8,9,10,10a-octahydro-indolo[4,3-fg]quinoline-9-carboxylic acid ((2R,5S,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxo-octahydro-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-amide
7-Methyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid (5-benzyl-10b-hydroxy-2-methyl-3,6-dioxo-octahydro-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-amide
9,10alpha-Dihydro-12 -hydroxy-2 -methyl-5 alpha-(phenylmethyl)ergotaman-3 ,6 ,18-trione
Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'.alpha.,10.alpha.)-